Literature DB >> 26342607

Reproductive factors, adiposity, breastfeeding and their associations with ovarian cancer in an Asian cohort.

Gibson Ming Wei Gay1, Jane Shu Ping Lim1, Wen Yee Chay2, Khuan Yew Chow3, Min Han Tan2, Wei-Yen Lim4.   

Abstract

PURPOSE: The aim of this study was to assess associations of breastfeeding, adiposity and reproductive risk factors with ovarian cancer risk in a Singaporean population. In addition to the main analysis, interaction effects of parity on other risk factors were examined.
METHODS: A retrospective cohort consisting of 28,201 women with 107 incident ovarian cancers in up to 17 years of follow-up from the Singapore Breast Cancer Screening Project (1994-1997) was studied. Hazard ratios (HRs) for risk factors were estimated using Cox proportional hazards models.
RESULTS: Body mass index and breastfeeding were found to have no statistical significant association with ovarian cancer risk. Gravidity was inversely associated with ovarian cancer risk [each pregnancy, adjusted HR 0.89, 95% confidence interval (CI) 0.81, 0.97], while results for parity were very similar (per delivery, HR 0.89, 95% CI 0.81, 0.98). Each additional year of ovulatory period was found to increase ovarian cancer risk by 2% (HR 1.02, 95% CI 1.00, 1.04). Each year increase in total duration of oral contraceptive use reduced ovarian cancer risk by 6% (HR 0.94, 95% CI 0.85, 1.02).
CONCLUSIONS: Parity, gravidity and shorter ovulatory period were associated with lower ovarian cancer risk. Breastfeeding and body mass index were not associated with ovarian cancer risk, while increased duration of oral contraceptive use resulted in borderline risk reduction. No significant evidence was found to suggest that parity had an interaction effect on any risk factor.

Entities:  

Keywords:  Asian; Breastfeeding; Obesity; Ovarian cancer; Reproductive factors; Risk factors

Mesh:

Year:  2015        PMID: 26342607     DOI: 10.1007/s10552-015-0649-6

Source DB:  PubMed          Journal:  Cancer Causes Control        ISSN: 0957-5243            Impact factor:   2.506


  5 in total

Review 1.  Association of Combined Estrogen-Progestogen and Progestogen-Only Contraceptives with the Development of Cancer.

Authors:  William V Williams; Louise A Mitchell; S Kathleen Carlson; Kathleen M Raviele
Journal:  Linacre Q       Date:  2019-01-03

2.  Epidemiology of ovarian cancer: a review.

Authors:  Brett M Reid; Jennifer B Permuth; Thomas A Sellers
Journal:  Cancer Biol Med       Date:  2017-02       Impact factor: 4.248

3.  Ovarian cancer proliferation and apoptosis are regulated by human transfer RNA methyltransferase 9-likevia LIN9.

Authors:  Huai Mei Chen; Jia Wang; Ying Feng Zhang; Yan Hong Gao
Journal:  Oncol Lett       Date:  2017-08-14       Impact factor: 2.967

4.  Age at menarche and epithelial ovarian cancer risk: A meta-analysis and Mendelian randomization study.

Authors:  Huijun Yang; Hongji Dai; Lian Li; Xin Wang; Peishan Wang; Fengju Song; Ben Zhang; Kexin Chen
Journal:  Cancer Med       Date:  2019-05-30       Impact factor: 4.452

5.  Germline PALB2, ATM variants in a patient with breast and ovarian cancer at risk for familial cancer syndrome: Is there a role for risk-reducing salpingo-oophorectomy?

Authors:  Semiramis L Carbajal-Mamani; Merry J Markham; Joaquín Santolaya-Forgas; Jacqueline C Castagno; Joel Cardenas-Goicoechea
Journal:  Obstet Gynecol Sci       Date:  2020-02-05
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.